H. Lang

47 papers receiving 484 citations

Peers

H. Lang
Comparison fields: 5 of 63
  • Pulmonary and Respiratory Medicine 311
  • Urology 46
  • Cancer Research 78
  • Oncology 122
  • Rheumatology 47
Replace Zike Qin with:
Zike Qin China
Benjamin Namdarian Australia
Tetsuya Imao Japan
Kersten Fischer Germany
Kiran Gollapudi United States
Sebastian Frees Germany
Osama Hussein Egypt
Sadatsugu Minei Japan
Rebecca Pedersini Italy
Hüseyi̇n Baloğlu Türkiye
H. Lang relative to Zike Qin China Zike Qin's profile →
Citations per field
00.5×
Zike Qin · 1×
Citations per year

Countries citing papers authored by H. Lang

Since Specialization
Citations

This map shows the geographic impact of H. Lang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Lang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Lang more than expected).

Fields of papers citing papers by H. Lang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Lang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Lang. The network helps show where H. Lang may publish in the future.

Co-authors

The 25 scholars most cited alongside H. Lang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with H. Lang Line = papers co-authored together H. Lang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2010115
2 201339
3 201031
4 200731
5 201026
6 201323
7 200721
8 200817
9
Comparison between long-term treatment of chronic bronchitic airway obstruction with ipratropium bromide and metaproterenol.
198414
10 200613
11 200812
12 201312
13 200812
14 199712
15 201710
16 20149
17 20039
18 20108
19 20087
20 20137

About H. Lang

H. Lang is a scholar working on Pulmonary and Respiratory Medicine, Urology, Rheumatology, Surgery and Molecular Biology, having authored 49 papers that have together received 501 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (20 papers), Renal and related cancers (17 papers), Pelvic floor disorders treatments (7 papers), Urinary Bladder and Prostate Research (5 papers), Pediatric Urology and Nephrology Studies (5 papers), MRI in cancer diagnosis (4 papers), Multiple and Secondary Primary Cancers (4 papers) and Bladder and Urothelial Cancer Treatments (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (311 citations), Urology (46 citations), Cancer Research (78 citations), Oncology (122 citations) and Rheumatology (47 citations). H. Lang has collaborated with scholars based in France, Germany and United States. Frequent co-authors include Didier Jacqmin, Bernard Escudier, Catherine Roy, Stéphane Oudard, Benoit Beuselinck, C. Saussine, Véronique Lindner, T. Charles, Pascal Wolter and Aurore Blesius. Their work appears in journals such as Progrès en Urologie, British Journal of Cancer, Clinical Chemistry and Laboratory Medicine (CCLM), Clinical Radiology and Carcinogenesis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026